Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
726,088
-
Shares change
-
-72,658
-
Total reported value, excl. options
-
$17,232,000
-
Value change
-
-$1,435,931
-
Number of buys
-
4
-
Number of sells
-
-6
-
Price
-
$23.75
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2014
13 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2014.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 726,088 shares
.
Largest 10 shareholders include Aperio Group, LLC (290,284 shares), Parametric Portfolio Associates LLC (247,212 shares), World Asset Management Inc (88,830 shares), RMB Capital Management, LLC (76,670 shares), Calvert Investment Management Inc. (12,772 shares), AMERIPRISE FINANCIAL INC (8,633 shares), Hexavest Inc. (1,134 shares), GLENMEDE TRUST CO NA (326 shares), PRIVATE TRUST CO NA (227 shares), and ZEVIN ASSET MANAGEMENT LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.